Literature DB >> 24074599

Receptor specificity does not affect replication or virulence of the 2009 pandemic H1N1 influenza virus in mice and ferrets.

Seema S Lakdawala1, Angela R Shih, Akila Jayaraman, Elaine W Lamirande, Ian Moore, Myeisha Paskel, Heather Kenney, Ram Sasisekharan, Kanta Subbarao.   

Abstract

Human influenza viruses predominantly bind α2,6 linked sialic acid (SA) while avian viruses bind α2,3 SA-containing complex glycans. Virulence and tissue tropism of influenza viruses have been ascribed to this binding preference. We generated 2009 pandemic H1N1 (pH1N1) viruses with either predominant α2,3 or α2,6 SA binding and evaluated these viruses in mice and ferrets. The α2,3 pH1N1 virus had similar virulence in mice and replicated to similar titers in the respiratory tract of mice and ferrets as the α2,6 and WT pH1N1 viruses. Immunohistochemical analysis determined that all viruses infected similar cell types in ferret lungs. There is increasing evidence that receptor specificity of influenza viruses is more complex than the binary model of α2,6 and α2,3 SA binding and our data suggest that influenza viruses use a wide range of SA moieties to infect host cells. Published by Elsevier Inc.

Entities:  

Keywords:  Influenza virus; Receptor specificity; Replication; Tissue tropism; Virulence

Mesh:

Substances:

Year:  2013        PMID: 24074599      PMCID: PMC3810034          DOI: 10.1016/j.virol.2013.08.011

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  50 in total

1.  Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus.

Authors:  Rui Xu; Damian C Ekiert; Jens C Krause; Rong Hai; James E Crowe; Ian A Wilson
Journal:  Science       Date:  2010-03-25       Impact factor: 47.728

2.  Generation of live attenuated novel influenza virus A/California/7/09 (H1N1) vaccines with high yield in embryonated chicken eggs.

Authors:  Zhongying Chen; Weijia Wang; Helen Zhou; Amorsolo L Suguitan; Cindy Shambaugh; Lomi Kim; Jackie Zhao; George Kemble; Hong Jin
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

3.  Comparison of a live attenuated 2009 H1N1 vaccine with seasonal influenza vaccines against 2009 pandemic H1N1 virus infection in mice and ferrets.

Authors:  Grace L Chen; Ji-Young Min; Elaine W Lamirande; Celia Santos; Hong Jin; George Kemble; Kanta Subbarao
Journal:  J Infect Dis       Date:  2011-01-21       Impact factor: 5.226

4.  Key molecular factors in hemagglutinin and PB2 contribute to efficient transmission of the 2009 H1N1 pandemic influenza virus.

Authors:  Ying Zhang; Qianyi Zhang; Yuwei Gao; Xijun He; Huihui Kong; Yongping Jiang; Yuntao Guan; Xianzhu Xia; Yuelong Shu; Yoshihiro Kawaoka; Zhigao Bu; Hualan Chen
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

5.  Eurasian-origin gene segments contribute to the transmissibility, aerosol release, and morphology of the 2009 pandemic H1N1 influenza virus.

Authors:  Seema S Lakdawala; Elaine W Lamirande; Amorsolo L Suguitan; Weijia Wang; Celia P Santos; Leatrice Vogel; Yumiko Matsuoka; William G Lindsley; Hong Jin; Kanta Subbarao
Journal:  PLoS Pathog       Date:  2011-12-29       Impact factor: 6.823

6.  Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells.

Authors:  Aida Ibricevic; Andrew Pekosz; Michael J Walter; Celeste Newby; John T Battaile; Earl G Brown; Michael J Holtzman; Steven L Brody
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

7.  Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets.

Authors:  Vincent J Munster; Emmie de Wit; Judith M A van den Brand; Sander Herfst; Eefje J A Schrauwen; Theo M Bestebroer; David van de Vijver; Charles A Boucher; Marion Koopmans; Guus F Rimmelzwaan; Thijs Kuiken; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  Science       Date:  2009-07-02       Impact factor: 47.728

8.  The mouse model for influenza.

Authors:  Yumiko Matsuoka; Elaine W Lamirande; Kanta Subbarao
Journal:  Curr Protoc Microbiol       Date:  2009-05

9.  Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets.

Authors:  Amorsolo L Suguitan; Josephine McAuliffe; Kimberly L Mills; Hong Jin; Greg Duke; Bin Lu; Catherine J Luke; Brian Murphy; David E Swayne; George Kemble; Kanta Subbarao
Journal:  PLoS Med       Date:  2006-09       Impact factor: 11.069

10.  Glycomic analysis of human respiratory tract tissues and correlation with influenza virus infection.

Authors:  Trevenan Walther; Rositsa Karamanska; Renee W Y Chan; Michael C W Chan; Nan Jia; Gillian Air; Clark Hopton; Maria P Wong; Anne Dell; J S Malik Peiris; Stuart M Haslam; John M Nicholls
Journal:  PLoS Pathog       Date:  2013-03-14       Impact factor: 6.823

View more
  13 in total

1.  Mapping of Influenza Virus RNA-RNA Interactions Reveals a Flexible Network.

Authors:  Valerie Le Sage; Jack P Kanarek; Dan J Snyder; Vaughn S Cooper; Seema S Lakdawala; Nara Lee
Journal:  Cell Rep       Date:  2020-06-30       Impact factor: 9.423

Review 2.  Influenza virus replication in macrophages: balancing protection and pathogenesis.

Authors:  Troy D Cline; Donald Beck; Elizabeth Bianchini
Journal:  J Gen Virol       Date:  2017-09-08       Impact factor: 3.891

3.  Effect of receptor binding specificity on the immunogenicity and protective efficacy of influenza virus A H1 vaccines.

Authors:  Xiangjie Sun; Weiping Cao; Claudia Pappas; Feng Liu; Jacqueline M Katz; Terrence M Tumpey
Journal:  Virology       Date:  2014-07-30       Impact factor: 3.616

Review 4.  A Guide for the Use of the Ferret Model for Influenza Virus Infection.

Authors:  Jessica A Belser; Alissa M Eckert; Thanhthao Huynh; Joy M Gary; Jana M Ritter; Terrence M Tumpey; Taronna R Maines
Journal:  Am J Pathol       Date:  2019-10-23       Impact factor: 4.307

5.  The humanized DRAGA mouse (HLA-A2. HLA-DR4. RAG1 KO. IL-2R g c KO. NOD) establishes inducible and transmissible models for influenza type A infections.

Authors:  Mirian Mendoza; Devi Gunasekera; Kathleen P Pratt; Qi Qiu; Sofia Casares; Teodor-D Brumeanu
Journal:  Hum Vaccin Immunother       Date:  2020-03-04       Impact factor: 3.452

6.  Functional balance between the hemagglutinin and neuraminidase of influenza A(H1N1)pdm09 HA D222 variants.

Authors:  Jean-Sébastien Casalegno; Olivier Ferraris; Vanessa Escuret; Maude Bouscambert; Corinne Bergeron; Laetitia Linès; Thierry Excoffier; Martine Valette; Emilie Frobert; Sylvie Pillet; Bruno Pozzetto; Bruno Lina; Michèle Ottmann
Journal:  PLoS One       Date:  2014-08-13       Impact factor: 3.240

7.  Dose-response models for selected respiratory infectious agents: Bordetella pertussis, group a Streptococcus, rhinovirus and respiratory syncytial virus.

Authors:  Rachael M Jones; Yu-Min Su
Journal:  BMC Infect Dis       Date:  2015-02-24       Impact factor: 3.090

8.  A GFP expressing influenza A virus to report in vivo tropism and protection by a matrix protein 2 ectodomain-specific monoclonal antibody.

Authors:  Sarah De Baets; Judith Verhelst; Silvie Van den Hoecke; Anouk Smet; Michael Schotsaert; Emma R Job; Kenny Roose; Bert Schepens; Walter Fiers; Xavier Saelens
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

9.  The soft palate is an important site of adaptation for transmissible influenza viruses.

Authors:  Seema S Lakdawala; Akila Jayaraman; Rebecca A Halpin; Elaine W Lamirande; Angela R Shih; Timothy B Stockwell; Xudong Lin; Ari Simenauer; Christopher T Hanson; Leatrice Vogel; Myeisha Paskel; Mahnaz Minai; Ian Moore; Marlene Orandle; Suman R Das; David E Wentworth; Ram Sasisekharan; Kanta Subbarao
Journal:  Nature       Date:  2015-09-23       Impact factor: 49.962

10.  Insights into the human glycan receptor conformation of 1918 pandemic hemagglutinin-glycan complexes derived from nuclear magnetic resonance and molecular dynamics studies.

Authors:  Stefano Elli; Eleonora Macchi; Timothy R Rudd; Rahul Raman; Guillherme Sassaki; Karthik Viswanathan; Edwin A Yates; Zachary Shriver; Annamaria Naggi; Giangiacomo Torri; Ram Sasisekharan; Marco Guerrini
Journal:  Biochemistry       Date:  2014-06-20       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.